Edwards Lifesciences (EW) Financials: Revenue & Earnings

EW$104.97+0.96 +0.92%
Medical - DevicesLarge CapHigh Quality
Compare
Market cap$60.36BEnterprise value$54.87BRevenue (TTM)$6.67BMarket positionTop 25%

Score

47
Neutral
Value
22
Quality
76
Growth
44

Financial Summary

Edwards Lifesciences Corporation (EW) last printed $104.97. Equity value is $60.36B. Trailing earnings multiple 58.56. The revenue row is reported history.

Financials

2016201720182019202020212022202320242025
$2.96B$3.44B$3.72B$4.35B$4.39B$5.23B$5.38B$5.01B$5.44B$6.07B

Edwards Lifesciences (EW) Financials: Revenue & Earnings

EW price $104.97 +0.96 +0.92%

Ticker
EW
Price
$104.97
Change
+0.96 +0.92%
Market cap
$60.36B
P/E
58.56
Forward P/E
31.98
Dividend yield
0.00%
Beta
0.85
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
47
Value
22
Quality
76
Growth
44

Stocklytics score rationale: value 22, quality 76, growth 44.

AI Score 70. Edwards Lifesciences Corporation has a strong market cap of $57.3 billion and impressive gross profit margins of approximately 78.1%. However, its high price-to-earnings ratio of 56.1 and negative price-to-earnings growth ratio indicate potential overvaluation, which may limit future growth prospects

Insights · Forecast · Financials · Learn

Stocklytics home · Screener